People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acetylon Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $33.6M | $433.2M | 2011 |
James A. Bradner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James A. Bradner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc A. Cohen | 1 | 5 |
| Kenneth Anderson | 1 | 5 |
| Elena A. Prokupets | 1 | 3 |
| Kenneth A. Anderson | 1 | 2 |
| WALTER C. OGIER | 1 | 2 |
| Elena Prokupets | 1 | 2 |
| Bruce L. Downey | 1 | 2 |
| Walter A. Ogier | 1 | 2 |
| Bruce A. Downey | 1 | 1 |
| James Bradner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.